Seroprevalence of chikungunya virus infection and co-occurrence with malaria among patients with febrile illness in Oguma, the middle belt region of Nigeria.
{"title":"Seroprevalence of chikungunya virus infection and co-occurrence with malaria among patients with febrile illness in Oguma, the middle belt region of Nigeria.","authors":"Matthew Jere Daudu, Cornelius Arome Omatola","doi":"10.1080/15321819.2026.2661007","DOIUrl":null,"url":null,"abstract":"<p><p>Globally, chikungunya virus infection has become a major public health concern due to the frequent epidemics and increased introduction into new regions. The current study provided a baseline report of chikungunya virus infection and its co-infection in the previously unexplored Oguma, Bassa Local Government Area. Blood samples and relevant sociodemographic variables were obtained from a cross-section of 200 febrile patients. Samples were screened serologically for chikungunya virus antibodies and microscopically for malaria parasites. Overall, anti-chikungunya virus antibodies were detected in 9(4.50%), out of which IgM and IgG were 4(2.0%) and 5(2.5%), respectively. Three (1.5%) of the patients with active chikungunya virus infection were co-infected with malaria, while 1(1.0%) was positive for viral mono-infection. Sixty (30%) patients in the study had malaria alone. Active cases of chikungunya virus infection were observed in males only [4(4.3%) vs 0(0.0%)], who also showed evidence of previous viral infection [3(3.3%) vs 2(1.9%)]. Among the small group of positive cases, rash and back pain were frequently observed alongside active chikungunya virus infection (<i>p</i> < 0.05). Our study confirms the circulation of the chikungunya virus in the unexplored Oguma area, though at a low level when compared to other epidemiological investigations elsewhere in the country.</p>","PeriodicalId":15990,"journal":{"name":"Journal of immunoassay & immunochemistry","volume":" ","pages":"1-15"},"PeriodicalIF":0.0000,"publicationDate":"2026-04-26","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Journal of immunoassay & immunochemistry","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1080/15321819.2026.2661007","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Health Professions","Score":null,"Total":0}
引用次数: 0
Abstract
Globally, chikungunya virus infection has become a major public health concern due to the frequent epidemics and increased introduction into new regions. The current study provided a baseline report of chikungunya virus infection and its co-infection in the previously unexplored Oguma, Bassa Local Government Area. Blood samples and relevant sociodemographic variables were obtained from a cross-section of 200 febrile patients. Samples were screened serologically for chikungunya virus antibodies and microscopically for malaria parasites. Overall, anti-chikungunya virus antibodies were detected in 9(4.50%), out of which IgM and IgG were 4(2.0%) and 5(2.5%), respectively. Three (1.5%) of the patients with active chikungunya virus infection were co-infected with malaria, while 1(1.0%) was positive for viral mono-infection. Sixty (30%) patients in the study had malaria alone. Active cases of chikungunya virus infection were observed in males only [4(4.3%) vs 0(0.0%)], who also showed evidence of previous viral infection [3(3.3%) vs 2(1.9%)]. Among the small group of positive cases, rash and back pain were frequently observed alongside active chikungunya virus infection (p < 0.05). Our study confirms the circulation of the chikungunya virus in the unexplored Oguma area, though at a low level when compared to other epidemiological investigations elsewhere in the country.
期刊介绍:
The Journal of Immunoassay & Immunochemistry is an international forum for rapid dissemination of research results and methodologies dealing with all aspects of immunoassay and immunochemistry, as well as selected aspects of immunology. They include receptor assay, enzyme-linked immunosorbent assay (ELISA) in all of its embodiments, ligand-based assays, biological markers of ligand-receptor interaction, in vivo and in vitro diagnostic reagents and techniques, diagnosis of AIDS, point-of-care testing, clinical immunology, antibody isolation and purification, and others.